ATUL
NSE: ATULCompany page on Cofacto
Open the ATUL page

Atul Limited (ATUL) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Cofacto Research Published October 18, 2026 5 min read

Atul Limited, a Lalbhai Group integrated chemical company making around 900 products across plants in India and the UK, reports its Q2 FY 2026-2027 numbers with the chemicals sector riding strong textile and chemical export growth but a sub-par monsoon weighing on agrochemical demand. The print will speak to whether the sharp Q1 FY27 earnings recovery holds — and whether consolidated EBITDA margins sustain after a one-off inventory drawdown flattered the June quarter.

Quick Details
Results dateOctober 23, 2026
QuarterQ2 FY 2026-2027
Previous quarter revenueRs. 1,847.95 Cr (consolidated, Q1 FY27)
Previous quarter PATRs. 253.93 Cr (consolidated, Q1 FY27)
Market capRs. 18,243.58 Cr
CMPRs. 6,196.50

Atul Limited Q2 Results Date and Time

The Board of Directors will meet on Friday, October 23, 2026, to consider the unaudited standalone and consolidated financial results for the quarter and six months ending September 30, 2026. The trading window remained closed October 1-25, 2026 under SEBI (PIT) Regulations, 2015.

What to expect from Atul Limited's Q2 FY27 results

The quarter enters with strong momentum — Q1 FY27 consolidated revenue grew 25.03% YoY to a record Rs. 1,847.95 Cr and consolidated PAT rose 91.85% YoY — but the key test is whether margins hold, since Q1's 21.41% EBITDA margin was flattered by a Rs. 187.77 Cr inventory drawdown that the company's own results pulse called 'a timing effect, not sustainable'. Demand support comes from textile exports up 16.1% YoY in August and 19.87% in September and chemical exports up 14% in August, while the soft leg is agro: cumulative monsoon rainfall was about 38% below LPA into early August, kharif acreage down 1.8%, and Chinese crop-protection export volumes down 15% YoY quarter-to-date in 2QFY27 — a headwind for the kharif-linked Agriculture vertical. On costs, the phenoxy input chain stayed benign, with o-cresol at a 1-year price 'Low' in China and MCA at USD 671/MT on the latest India print, though cost of materials grew 39.4% YoY in Q1, faster than revenue. A weaker rupee — September monthly average of 95.50, with the currency down about 8% in 2026 — supports translated export realisations through the six international subsidiaries. There is no revenue or margin guidance on record to test; the only quantified commitments are the Rs. 167 Cr MCPP-p (1,000 tpa) and MCPA (750 tpa) build within 67 weeks of the July 24, 2026 approval, funded from internal accruals, and the 13.2 MW Torrent Urja 39 hybrid power supply commencing by end-March 2027, so any quantified outlook on the October 23 call would be first-time information.

Key Things To Watch

Margin trajectory and inventory drawdown reversal: Whether the Q1 FY27 margin gain was structural or timing-driven.

  • Whether consolidated EBITDA% holds near Q1 FY27's 21.41% or repeats the compression from 20% in Q2 FY26 to 18% in Q3 FY26
  • How much of Q1's gain came from the Rs. 187.77 Cr inventory drawdown reversing, with cost of materials up 39.4% YoY against revenue growth of 25.03%

Rs. 167 Cr phenoxy herbicides capex execution: First balance-sheet evidence of the newly approved build.

  • Status of the MCPP-p (1,000 tpa) and MCPA (750 tpa) facilities — both currently with nil existing capacity — against the 67-week completion window from the July 24, 2026 board approval
  • Funding confirmation via internal accruals against a net-cash cushion of about Rs. 2,440.52 Cr as of March 31, 2026

Effluent pipeline repairs and GPCB engagement: The October 16, 2026 incident is the near-term execution and reputational item into the print.

  • Update on resumption of treated effluent discharge — voluntarily suspended pending repairs to a damaged section about 1 km from the effluent treatment plant on the 4-km Par-estuary pipeline
  • Any GPCB engagement following the company's clarification that the released effluent complied with GPCB standards, and whether the suspension affected Q2 FY27; the company expects no material impact

Segment momentum and renewable power timeline: Whether Q1 FY27 segment pace sustains into H1.

  • Whether Performance & Other Chemicals (Rs. 1,427.44 Cr revenue; 16.80% segment results margin) and Life Science Chemicals (Rs. 469.23 Cr; 19.77%) sustain their Q1 FY27 pace
  • Confirmation that the 13.2 MW group captive hybrid power supply with M/s Torrent Urja 39 Pvt Ltd remains on track to commence by end of March 2027

Frequently Asked Questions

Is Atul Limited's revenue growing?

Yes — consolidated revenue rose 25.03% YoY to Rs. 1,847.95 Cr in Q1 FY27, with standalone revenue up 21.77% YoY to Rs. 1,588.60 Cr. The company characterised the quarter as reflecting 'robust growth in consolidated revenues and net profits'.

What new capacity is Atul Limited building?

The board approved Rs. 167 Cr of capex on July 24, 2026 for Mecoprop-p (1,000 tpa) and MCPA (750 tpa) facilities — both products with nil existing capacity — to be completed within 67 weeks and funded entirely from internal accruals. The stated rationale is to expand the portfolio, strengthen the position in Phenoxy herbicides, and produce value-added downstream products of o-Cresol and MCA.

What happened with Atul's effluent pipeline incident?

On October 16, 2026, Atul clarified that accidental damage to a section of its roughly 4-km effluent pipeline, laid within the Par estuary, caused a short-period release of treated effluent that the company says complied with GPCB prescribed standards. Discharge was voluntarily suspended pending repairs, and the company stated it does not expect any material impact due to this incident.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now